PHASE Scientiﬁc is a high-growth biotech company founded by bioengineers from UCLA. We build tools that empower people by giving them better information about their health. Now headquartered in Hong Kong, our global footprint includes R&D and manufacturing facilities in Southern
California and ofﬁces in Mainland China.
We endeavor to support patients and healthcare providers through the creation of innovative diagnostic and data tools that enable people to better understand their own health.
We believe everyone deserves access to the best knowledge about their health, and that higher quality information in the hands of more people leads to better decision-making.
new thinking and greater impact
As a patent attorney with a law practice in New York, Dr. Chan has assisted Nobel Prize winners, scientists, and start-ups obtain intellectual property protection and enforcement. With over 30 years of experience in IP law and a background in molecular biology, he uniquely meets the needs of the biotechnology industry. Beyond IP protection, Dr. Chan also has a great deal of experience in transactional work in licensing, joint ventures, and public listings. He currently holds Adjunct Professorship at several universities in Hong Kong.
Professor Featherstone is an expert in cariology (the study of tooth decay), and the founder of Caries Management by Risk Assessment (CAMBRA), a tool for understanding a patient’s risk in getting tooth decays.
He has won many awards for his work, including the Norton Ross Award for excellence in clinical research from the American Dental Association (2007), the Zsolnai Prize from the European Caries Research Organization (2002) for his lifelong contributions to caries research, and the Ericsson Prize in Preventive Dentistry by the Swedish Patent Fund (2002).
He is former Professor of Preventive and Restorative Dental Sciences at the University of California, San Francisco (UCSF) and Dean Emeritus of the UCSF School of Dentistry.
Mr. Jiang is a proven leader of the bioengineering and medical device industries in China. Combining his clinical training with business acumen, he has transformed and grown scores of companies through direct involvement and board membership.
In addition to advising companies, he also works to further the development of the industry. Among many positions in industry associations and the Government, he is Executive Vice President of the China Medical Device Industry Association, President of the National Medical Device Industry Innovation Strategic Alliance of the Ministry of Science and Technology, and Deputy Director of the Biomedical Engineering Education Steering Committee of the Ministry of Education.
Dr. Kamei is currently a Professor in the Department of Bioengineering at the University of California, Los Angeles (UCLA). He joined the faculty in 2003, and his research in paper microfluidic concentration has significantly impacted the core technology of PHASE. His work aims to continue to develop new technology to push the frontiers of diagnostics.
Professor Kamei has received multiple research awards, including the Coulter Early Career Award and the Kimmel Scholar Award. In addition to his research, Professor Kamei is also a dedicated teacher, and has been recognized by multiple teaching awards at UCLA, including the UCLA Academic Senate Distinguished Teaching Award and the Lockheed Martin Excellence in Teaching Award.
Professor Klausner is an international expert in the prevention and control of infectious diseases, particularly of HIV, sexually transmitted diseases (STDs) and tuberculosis (TB). He is a frequent advisor to the Centers for Disease Control and Prevention (CDC), the National Institutes of Health, and the World Health Organization.
Professor Klausner was previously Director of STD Prevention and Control for the San Francisco Department of Public Health. He was also the Branch Chief for HIV and TB for CDC in Pretoria, South Africa, where he helped lead The United States President’s Emergency Plan for AIDS Relief program there. He is a Professor of Medicine in the Division of Infectious Diseases and the Program in Global Health at the University of California, Los Angeles.
Professor Tam is a pioneer in the biotechnology and diagnostics industry in Hong Kong. He has retired from the Faculty of Medicine at the University of Hong Kong, having spent over three decades in teaching and research.
He is the Founder and President of the Hong Kong Biochemistry Association. He is an Honorary Associate Professor of the Li Ka Shing Faculty of Medicine, Hong Kong University, and a Visiting Professor at the University of California San Francisco, Baylor Medical College and the Medical College of Georgia. He is also the Founder and Chairman of DiagCor Bioscience Incorporation Limited.
A practicing clinician and biomaterial scientist, Professor Wu brings together expertise in multiple disciplines to provide patient care and develop solutions for unmet needs.
At the University of California, Los Angeles (UCLA), he is currently Professor and Chairman of the Division of Advanced Prosthodontics at the School of Dentistry, and Director of the Weintraub Center for Reconstructive Biotechnology. He is also Professor and past Chairman of Bioengineering and of Materials Science at the School of Engineering, and Professor of Orthopedic Surgery at the School of Medicine.
He serves on numerous advisory boards for government, academia and industry, and is also a fellow of the Academy of Prosthodontics.
CONNECT WITH US
comments or suggestions,
please contact us